HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
26 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
CD209
CD209 molecule
Chromosome 19 · 19p13.2
NCBI Gene: 30835Ensembl: ENSG00000090659.18HGNC: HGNC:1641UniProt: B2R907
469PubMed Papers
20Diseases
0Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
Hub GeneReceptor
RESEARCH IMPACT
Highly StudiedTrending
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
immature T cell proliferationdendritic cell migrationpositive regulation of T cell proliferationsymbiont entry into host celldengue diseaseneurodegenerative diseaseHIV-1 infectiongastric adenocarcinoma
✦AI Summary

CD209 (DC-SIGN) is a C-type lectin pattern recognition receptor expressed on dendritic cells and macrophages that mediates pathogen recognition and immune regulation 1. The molecule recognizes high-mannose N-linked oligosaccharides on various microbial pathogens in a calcium-dependent manner, including Mycobacterium tuberculosis, Helicobacter pylori, and Leishmania species 2. CD209 serves as both a pathogen recognition receptor and an alternative entry point for enveloped viruses including SARS-CoV-2, dengue virus, and Zika virus, though in vivo studies suggest it plays only a partial role in viral infection 3. In macrophage biology, CD209 expression marks alternatively activated (M2) macrophages with high endocytic capacity 4. The molecule is essential for dendritic cell migration and T cell activation, contributing to both primary immune responses and immunoregulation 1. Genetic variants in CD209 promoter regions (-871A/G and -336A/G polymorphisms) are associated with tuberculosis susceptibility, particularly in Asian populations, where certain genotypes confer increased risk 56. Elevated CD209 plasma levels show association with increased varicose vein risk 7. CD209 expression on tumor-associated macrophages correlates with distinct functional phenotypes related to phagocytosis and angiogenesis 8.

Sources cited
1
CD209 (DC-SIGN) is a C-type lectin pattern recognition receptor with immunoregulatory roles in dendritic cells, mediating adhesion, migration, inflammation, and T cell activation
PMID: 16978536
2
CD209 recognizes high-mannose oligosaccharides on bacterial pathogens including M. tuberculosis, H. pylori, Leishmania, and Schistosoma in a calcium-dependent manner
PMID: 16379498
3
CD209 and CD209L serve as alternative receptors for multiple viruses including SARS-CoV-2, dengue, Zika, Ebola, and Marburg viruses, though blocking these receptors provides only partial protection in vivo
PMID: 39783143
4
CD209 expression marks alternatively activated (M2) macrophages with enhanced endocytic capacity
PMID: 25870903
5
CD209 -871A/G polymorphism is associated with decreased tuberculosis susceptibility overall, while -336A/G is associated with increased susceptibility in Asian populations
PMID: 26722430
6
CD209 -336A/G GG genotype increases tuberculosis susceptibility in Asian populations
PMID: 22911807
7
Genetically predicted increased CD209 plasma levels are associated with increased varicose vein risk
PMID: 35594287
8
CD209high and CD209low tumor-associated macrophage subpopulations display distinct functional characteristics related to phagocytosis and angiogenesis
PMID: 36438481
Disease Associationsⓘ20
dengue diseaseOpen Targets
0.53Moderate
neurodegenerative diseaseOpen Targets
0.37Weak
HIV-1 infectionOpen Targets
0.24Weak
gastric adenocarcinomaOpen Targets
0.22Weak
squamous cell lung carcinomaOpen Targets
0.22Weak
melanomaOpen Targets
0.19Weak
hepatocellular carcinomaOpen Targets
0.19Weak
lung adenocarcinomaOpen Targets
0.19Weak
esophageal squamous cell carcinomaOpen Targets
0.19Weak
oral squamous cell carcinomaOpen Targets
0.19Weak
lung carcinomaOpen Targets
0.19Weak
head and neck squamous cell carcinomaOpen Targets
0.19Weak
colorectal adenocarcinomaOpen Targets
0.19Weak
acute myeloid leukemiaOpen Targets
0.19Weak
gliomaOpen Targets
0.19Weak
cutaneous melanomaOpen Targets
0.19Weak
osteosarcomaOpen Targets
0.19Weak
breast carcinomaOpen Targets
0.19Weak
rectal adenocarcinomaOpen Targets
0.19Weak
urinary bladder carcinomaOpen Targets
0.19Weak
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Related Genes
CCR5Protein interaction100%MBL2Protein interaction100%SCARB1Protein interaction100%IFNGProtein interaction99%LSP1Protein interaction99%SYKProtein interaction98%
Tissue Expression6 tissues
Heart
100%
Lung
61%
Liver
27%
Brain
22%
Ovary
18%
Bone Marrow
11%
Gene Interaction Network
Click a node to explore
CD209CCR5MBL2SCARB1IFNGLSP1SYK
PROTEIN STRUCTURE
Preparing viewer…
PDB2XR6 · 1.35 Å · X-ray
View on RCSB ↗
Constraintⓘ
LOEUFⓘ
0.95LoF Tolerant
pLIⓘ
0.00Tolerant
Observed/Expected LoF0.70 [0.52–0.95]
RankingsWhere CD209 stands among ~20K protein-coding genes
  • #574of 20,598
    Most Researched469 · top 5%
  • #8,825of 17,882
    Most Constrained (LOEUF)0.95
Genes detectedCD209
Sources retrieved26 papers
Response time—
📄 Sources
26▼
1
Phenotypic, functional, and plasticity features of classical and alternatively activated human macrophages.
PMID: 25870903
Am J Respir Cell Mol Biol · 2015
1.00
2
The association between CD209 gene polymorphisms and pulmonary tuberculosis susceptibility: a meta-analysis.
PMID: 26722430
Int J Clin Exp Pathol · 2015
0.90
3
Signatures of EMT, immunosuppression, and inflammation in primary and recurrent human cutaneous squamous cell carcinoma at single-cell resolution.
PMID: 36438481
Theranostics · 2022
0.80
4
ACE2-Independent Alternative Receptors for SARS-CoV-2.
PMID: 36423144
Viruses · 2022
0.80
5
A protocol for rapid monocyte isolation and generation of singular human monocyte-derived dendritic cells.
PMID: 32271804
PLoS One · 2020
0.70